Form 4: Inari Medical Director William Hoffman Sells 60,000 Shares

Director William Hoffman of Inari Medical, Inc. executed a sale of 60,000 shares of common stock on May 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 28, 2024, William Hoffman, a director of Inari Medical, Inc., sold 60,000 shares of common stock.
• The sale was executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
• The shares were sold at a weighted average price of $50.13, with individual trades ranging from $50.00 to $50.34.
• Following the transaction, Hoffman directly owns 865,359 shares of Inari Medical, Inc.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the sale was conducted under a pre-arranged trading plan, suggesting it was not based on new information or a change in the director's outlook for the company.

Industry Context

Sales by company insiders are a common occurrence and are closely watched by investors for signals about the company's prospects. A pre-planned sale under Rule 10b5-1 often mitigates concerns about insider information.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although the pre-planned nature of the sale may alleviate concerns.

Key Dates